About Radboud University Nijmegen Medical Centre
Het Radboudumc of voluit Radboud universitair medisch centrum is een academisch ziekenhuis in Nijmegen dat samenwerkt met de Radboud Universiteit. Het maakt deel uit van de Nederlandse Federatie van Universitair Medische Centra. Het ziekenhuis heeft in 2019 1065 bedden en bijna 11.000 medewerkers.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Radboud University Medical Center
149
European Organisation for Research and Treatment of Cancer - EORTC
61
Pfizer
11
Vertex Pharmaceuticals Incorporated
10
The Netherlands Cancer Institute
9
Maastricht University Medical Center
8
UMC Utrecht
7
Actelion
6
University Medical Center Groningen
6
AM-Pharma
5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
5
Clinical Trials at Radboud University Nijmegen Medical Centre
During the past decade, Radboud University Nijmegen Medical Centre conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 42 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 26 clinical trials were completed. i.e. 57.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
1988-04-01
Completed
224
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
1989-09-01
Active, not recruiting
615
Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
1992-07-01
Unknown status
Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
1992-10-01
Completed
204
Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
1993-04-01
2016-01-01
Completed
1,011
Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
1993-08-01
Completed
214
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
1993-11-01
Unknown status
1,520
High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
1994-02-01
Completed
338
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Radboud University Nijmegen Medical Centre" #1 sponsor was "Radboud University Medical Center" with 149 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 61 trials
sponsored, "Pfizer" with 11 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 10 trials sponsored and "The Netherlands Cancer Institute"
with 10 trials sponsored. Other sponsors include 155 different institutions and
companies that sponsored additional 103 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Radboud University Nijmegen Medical Centre"
#1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 29 trials as a collaborator, "Radboud University Medical Center" with 19 trials as a collaborator, "Dutch Cancer Society" with 14 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 7 trials as a collaborator and "AstraZeneca" with 6 trials as a collaborator. Other collaborators include 302 different institutions and companies that were
collaborators in the rest 224 trials.
Clinical Trials Conditions at Radboud University Nijmegen Medical Centre
According to Clinical.Site data, the most researched conditions in "Radboud University Nijmegen Medical Centre" are
"Breast Cancer" (12 trials), "Leukemia" (11 trials), "Colorectal Cancer" (10 trials), "Cystic Fibrosis" (10 trials) and "Prostate Cancer" (9 trials). Many other conditions were trialed in "Radboud University Nijmegen Medical Centre" in a lesser frequency.
Clinical Trials Intervention Types at Radboud University Nijmegen Medical Centre
Most popular intervention types in "Radboud University Nijmegen Medical Centre" are "Drug" (228 trials), "Other" (51 trials), "Procedure" (45 trials), "Biological" (40 trials) and "Radiation" (27 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (46 trials), "radiation therapy" (14 trials), "IVA" (10 trials), "cisplatin" (10 trials) and "cyclophosphamide" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Radboud University Nijmegen Medical Centre
The vast majority of trials in "Radboud University Nijmegen Medical Centre" are
336 trials for "All" genders, 41 trials for "Male" genders and 23 trials for "Female" genders.
Clinical Trials Status at Radboud University Nijmegen Medical Centre
Currently, there are 63 active trials in "Radboud University Nijmegen Medical Centre".
1 are not yet recruiting,
42 are recruiting,
16 are Active, not recruiting,
and 4 are Enrolling by invitation.
In total, there were 231 completed trials in Radboud University Nijmegen Medical Centre,
4 suspended trials,
and 36 terminated clinical trials to date.
Out of the total trials that were conducted in Radboud University Nijmegen Medical Centre, 43 "Phase 1"
clinical trials were conducted, 86 "Phase 2" clinical
trials and 112 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 29 trials, and there were
also 95 trials that are defined as “Not Applicable".